Pioneering nucleic acid breakthroughs for the world
Nucleic Acid Insights 2024; 1(1), 37–41
DOI: 10.18609/nai.2024.007
Published: 23 February
Interview
Robert Langer
The COVID-19 mRNA vaccines amply demonstrated the potential of nucleic acid-based medicines to reshape healthcare on a truly global basis. David McCall, Senior Editor, Nucleic Acid Insights, speaks toRobert Langer, David H Koch Institute Professor, Massachusetts Institute of Technology, about building on his enormous legacy as a founding father of nucleic acid delivery by enabling worldwide patient access to novel vaccines and therapeutics alike.